Terms: = Bone cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Staging
31 results:
1. The prognostic role of next-generation imaging-driven upstaging in newly diagnosed prostate cancer patients.
Bauckneht M; Checcucci E; Cisero E; Rizzo A; Racca M; De Cillis S; Amparore D; De Luca S; Fiori C; Rescigno P; Porpiglia F
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):864-870. PubMed ID: 37935995
[TBL] [Abstract] [Full Text] [Related]
2. Myeloid/Lymphoid Neoplasm with FGFR1 Rearrangement Presenting with Polycythemia Vera and T-cell Acute Lymphoblastic Leukemia.
Marinelli LM; Romain JT; Ehman W; Ortega V; Velagaleti G; Gibbons TF; Nazario-Toole A; Holmes AR
Cancer Genet; 2023 Aug; 276-277():43-47. PubMed ID: 37480761
[TBL] [Abstract] [Full Text] [Related]
3. Recurrence rate after radical prostatectomy following primary staging of high-risk prostate cancer with
Klingenberg S; Fredsøe J; Sørensen KD; Ulhøi BP; Borre M; Jochumsen MR; Bouchelouche K
Acta Oncol; 2022 Oct; 61(10):1289-1294. PubMed ID: 36199168
[TBL] [Abstract] [Full Text] [Related]
4.
Pfister D; Haidl F; Nestler T; Verburg F; Schmidt M; Wittersheim M; Steib F; Heidenreich A
BJU Int; 2020 Dec; 126(6):679-683. PubMed ID: 32531840
[TBL] [Abstract] [Full Text] [Related]
5. The clinical efficacy of PSMA PET/MRI in biochemically recurrent prostate cancer compared with standard of care imaging modalities and confirmatory histopathology: results of a single-centre, prospective clinical trial.
Joshi A; Roberts MJ; Perera M; Williams E; Rhee H; Pryor D; Lehman M; Heathcote P; Wood S; Coucher J; Gustafson S; Miles K; Vela I
Clin Exp Metastasis; 2020 Aug; 37(4):551-560. PubMed ID: 32519046
[TBL] [Abstract] [Full Text] [Related]
6. Application of [
Dadgar H; Emami F; Norouzbeigi N; Vafaee MS; Jafari E; Gholamrezanezhad A; Assadi M; Ahmadzadehfar H
Mol Imaging Biol; 2020 Aug; 22(4):1062-1069. PubMed ID: 31758511
[TBL] [Abstract] [Full Text] [Related]
7. Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancer.
Adeleke S; Latifoltojar A; Sidhu H; Galazi M; Shah TT; Clemente J; Davda R; Payne HA; Chouhan MD; Lioumi M; Chua S; Freeman A; Rodriguez-Justo M; Coolen A; Vadgama S; Morris S; Cook GJ; Bomanji J; Arya M; Chowdhury S; Wan S; Haroon A; Ng T; Ahmed HU; Punwani S
BMC Med Imaging; 2019 Nov; 19(1):90. PubMed ID: 31730466
[TBL] [Abstract] [Full Text] [Related]
8. Total-Body
Pomykala KL; Czernin J; Grogan TR; Armstrong WR; Williams J; Calais J
J Nucl Med; 2020 Mar; 61(3):405-411. PubMed ID: 31541035
[TBL] [Abstract] [Full Text] [Related]
9. Evaluating and Predicting the Probability of Death in Patients with Non-Metastatic Osteosarcoma: A Population-Based Study.
Huang R; Xian S; Shi T; Yan P; Hu P; Yin H; Meng T; Huang Z
Med Sci Monit; 2019 Jun; 25():4675-4690. PubMed ID: 31231119
[TBL] [Abstract] [Full Text] [Related]
10. Novel Imaging in Detection of Metastatic Prostate cancer.
Smith CP; Laucis A; Harmon S; Mena E; Lindenberg L; Choyke PL; Turkbey B
Curr Oncol Rep; 2019 Mar; 21(4):31. PubMed ID: 30834999
[TBL] [Abstract] [Full Text] [Related]
11. Detection Efficacy of
Giesel FL; Knorr K; Spohn F; Will L; Maurer T; Flechsig P; Neels O; Schiller K; Amaral H; Weber WA; Haberkorn U; Schwaiger M; Kratochwil C; Choyke P; Kramer V; Kopka K; Eiber M
J Nucl Med; 2019 Mar; 60(3):362-368. PubMed ID: 30042163
[TBL] [Abstract] [Full Text] [Related]
12. Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study.
Moreau P; Mateos MV; Berenson JR; Weisel K; Lazzaro A; Song K; Dimopoulos MA; Huang M; Zahlten-Kumeli A; Stewart AK
Lancet Oncol; 2018 Jul; 19(7):953-964. PubMed ID: 29866475
[TBL] [Abstract] [Full Text] [Related]
13. Diagnostic Performance of 18F-Fluciclovine in Detection of Prostate cancer bone Metastases.
Chau A; Gardiner P; Colletti PM; Jadvar H
Clin Nucl Med; 2018 Jul; 43(7):e226-e231. PubMed ID: 29762238
[TBL] [Abstract] [Full Text] [Related]
14. The use of PET/CT in prostate cancer.
Li R; Ravizzini GC; Gorin MA; Maurer T; Eiber M; Cooperberg MR; Alemozzaffar M; Tollefson MK; Delacroix SE; Chapin BF
Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):4-21. PubMed ID: 29230009
[TBL] [Abstract] [Full Text] [Related]
15.
Hassan A; Siddique M; Bashir H; Riaz S; Wali R; Mahreen A; Nawaz MK
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
[TBL] [Abstract] [Full Text] [Related]
16. Long-Term Prognostic Analysis after Endoscopic Endonasal Surgery for Olfactory Neuroblastoma: A Retrospective Study of 13 Cases.
Zhang L; Niu K; Zhu K; Xia C; Yan J; Zhao W; Wei J; Duan M; Zheng G
PLoS One; 2016; 11(11):e0166046. PubMed ID: 27806104
[TBL] [Abstract] [Full Text] [Related]
17. Chronic myeloid leukemia as a secondary malignancy after lymphoma in a child. A case report and review of the literature.
Zahra K; Ben Fredj W; Ben Youssef Y; Zaghouani H; Chebchoub I; Zaier M; Badreddine S; Braham N; Sennana H; Khelif A
Onkologie; 2012; 35(11):690-3. PubMed ID: 23147546
[TBL] [Abstract] [Full Text] [Related]
18. Extranodal non-hodgkin lymphomas of the oral cavity and maxillofacial region: a clinical study of 58 cases and review of the literature.
Triantafillidou K; Dimitrakopoulos J; Iordanidis F; Gkagkalis A
J Oral Maxillofac Surg; 2012 Dec; 70(12):2776-85. PubMed ID: 22494508
[TBL] [Abstract] [Full Text] [Related]
19. A case of diffuse-type primary hepatic lymphoma mimicking diffuse hepatocellular carcinoma.
Kaneko K; Nishie A; Arima F; Yoshida T; Ono K; Omagari J; Honda H
Ann Nucl Med; 2011 May; 25(4):303-7. PubMed ID: 21234726
[TBL] [Abstract] [Full Text] [Related]
20. Methylation status of DDIT3 gene in chronic myeloid leukemia.
Wang YL; Qian J; Lin J; Yao DM; Qian Z; Zhu ZH; Li JY
J Exp Clin Cancer Res; 2010 May; 29(1):54. PubMed ID: 20492726
[TBL] [Abstract] [Full Text] [Related]
[Next]
